This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1985.
Company Filing History:
1 out of 834,411 Years Active: 1985
Title: The Innovative Contributions of Ingrid L Grupp
Introduction
Ingrid L Grupp is a notable inventor based in Cincinnati, OH (US). She has made significant contributions to the field of pharmacology, particularly in the development of methods for administering calcium channel blocking agents. Her work has implications for improving the effectiveness of certain medications used in treating cardiovascular conditions.
Latest Patents
Ingrid L Grupp holds 1 patent for her invention titled "Method of administering calcium channel blocking agents." This patent describes a method of potentiating the effect of a dihydropyridine derivative, such as nimodipine or nifedipine, by administering d-cis-diltiazem in a specific manner. The method aims to inhibit calcium influx without causing a substantial decrease in contractility, thereby enhancing the therapeutic effects of the dihydropyridine derivative.
Career Highlights
Throughout her career, Ingrid has focused on innovative approaches to pharmacological treatments. Her research has contributed to a better understanding of how to optimize the use of calcium channel blockers, which are essential in managing various cardiovascular diseases. Her dedication to advancing medical science is evident in her patent and ongoing research efforts.
Collaborations
Ingrid has collaborated with notable professionals in her field, including Gunter Grupp and Alain De Pover. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in pharmacology.
Conclusion
Ingrid L Grupp's contributions to the field of pharmacology through her innovative patent demonstrate her commitment to improving medical treatments. Her work continues to influence the development of effective therapies for cardiovascular conditions.